Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 4
Submit an article Journal homepage
127
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Immunosuppressive Treatments for Myelodysplastic Syndromes

Takashi Shimamoto First Department of Internal Medicine, Tokyo Medical University, 6-7-1, Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
&
Kazuma Ohyashiki First Department of Internal Medicine, Tokyo Medical University, 6-7-1, Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
Pages 593-604 | Published online: 01 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Pearlie K Epling-Burnette, Jessica McDaniel, Sheng Wei & Alan F List. (2012) Emerging immunosuppressive drugs in myelodysplastic syndromes. Expert Opinion on Emerging Drugs 17:4, pages 519-541.
Read now

Articles from other publishers (15)

Hiroyoshi Kunimoto, Ayaka Miura, Ayaka Maeda, Naomi Tsuchida, Yuri Uchiyama, Yosuke Kunishita, Yuki Nakajima, Kaoru Takase-Minegishi, Ryusuke Yoshimi, Takuya Miyazaki, Maki Hagihara, Etsuko Yamazaki, Yohei Kirino, Naomichi Matsumoto & Hideaki Nakajima. (2023) Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome. International Journal of Hematology.
Crossref
Hideko Goto, Takeshi Hara, Kei Fujita, Yuto Kaneda, Kimihiro Yamaguchi, Yuhei Shibata, Senji Kasahara, Takeshi Takahashi & Hisashi Tsurumi. (2022) Unrelated bone marrow transplantation improves Crohn's disease in a patient with myelodysplastic syndrome that developed from aplastic anemia: A case report. World Academy of Sciences Journal 4:2.
Crossref
Yu Kyung Kim. (2016) A Case of Myelodysplastic Syndrome Characterized by Hemolytic Anemia at Presentation. Laboratory Medicine Online 6:1, pages 41.
Crossref
Tadashi Nagai, Eisuke Uehara, Kiriko Saito, Toyomi Kamesaki, Keiya Ozawa, Kazuo Muroi & Yoshinobu Kanda. (2015) COOMBS-NEGATIVE AUTOIMMUNE HEMOLYTIC ANEMIA ASSOCIATED WITH MYELODYSPLASTIC SYNDROME. Japanese Journal of Transfusion and Cell Therapy 61:4, pages 468-473.
Crossref
Thorsten Braun & Pierre Fenaux. (2013) Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): Cause or consequence?. Best Practice & Research Clinical Haematology 26:4, pages 327-336.
Crossref
Panagiotis T Diamantopoulos, Maria Michael, Olga Benopoulou, Efthymia Bazanis, George Tzeletas, John Meletis, George Vayopoulos & Nora-Athina Viniou. (2012) Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations. Virology Journal 9:1.
Crossref
Zhijian Xiao, Zefeng Xu, Yue Zhang, Tiejun Qin, Hongli Zhang & Liwei Fang. (2011) Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study. Leukemia Research 35:1, pages 61-65.
Crossref
Elaine M. SloandMatthew J. OlnesAarthie ShenoyBarbara WeinsteinCarol BossKelsey LoeligerColin O. WuKenneth MoreA. John BarrettPhillip ScheinbergNeal S. Young. (2010) Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improvement in Blood Counts and Cytogenetic Remissions. Journal of Clinical Oncology 28:35, pages 5166-5173.
Crossref
Tsutomu Shichishima, Kazuhiko Ikeda, Naoto Takahashi, Junichi Kameoka, Katsushi Tajima, Kazunori Murai, Yoshiko Tamai, Akiko Shichishima-Nakamura, Kazuko Akutsu, Hideyoshi Noji, Masatoshi Okamoto, Hideo Kimura, Hideo Harigae, Takashi Oyamada, Toyomi Kamesaki, Yasuchika Takeishi & Kenichi Sawada. (2010) Low concentration of serum haptoglobin has impact on understanding complex pathophysiology in patients with acquired bone marrow failure syndromes. International Journal of Hematology 91:4, pages 602-610.
Crossref
Tadashi Matsubayashi, Yoichiro Ohro, Tomoihiro Yagyuu & Jun Miyahara. (2008) Coexistence of T-cell Lymphoblastic Lymphoma and Myelodysplastic Syndrome in a Child. Journal of Pediatric Hematology/Oncology 30:9, pages 701-703.
Crossref
Takashi Iwasaki, Masashi Murakami, Chiho Sugisaki, Sayaka Sobue, Haruhiko Ohashi, Haruhiko Asano, Motoshi Suzuki, Shigeo Nakamura, Masafumi Ito & Takashi Murate. (2008) Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: Differential diagnosis between refractory anemia and aplastic anemia. Pathology International 58:6, pages 353-360.
Crossref
Elaine M. Sloand & Katayoun Rezvani. (2008) The Role of the Immune System in Myelodysplasia: Implications for Therapy. Seminars in Hematology 45:1, pages 39-48.
Crossref
Maren Weischer, Martin Röcken & Mark Berneburg. (2007) Calcineurin inhibitors and rapamycin: cancer protection or promotion?. Experimental Dermatology 16:5, pages 385-393.
Crossref
A. John Barrett, Elaine Sloand & Neal S. Young. 2009. Myelodysplastic Syndromes. Myelodysplastic Syndromes 147 172 .
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:3, pages 141-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.